JP2013544786A5 - - Google Patents

Download PDF

Info

Publication number
JP2013544786A5
JP2013544786A5 JP2013533941A JP2013533941A JP2013544786A5 JP 2013544786 A5 JP2013544786 A5 JP 2013544786A5 JP 2013533941 A JP2013533941 A JP 2013533941A JP 2013533941 A JP2013533941 A JP 2013533941A JP 2013544786 A5 JP2013544786 A5 JP 2013544786A5
Authority
JP
Japan
Prior art keywords
compound
chch
isobutyl
alkyl
propylthio
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2013533941A
Other languages
English (en)
Japanese (ja)
Other versions
JP5805773B2 (ja
JP2013544786A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2011/055788 external-priority patent/WO2012051193A1/en
Publication of JP2013544786A publication Critical patent/JP2013544786A/ja
Publication of JP2013544786A5 publication Critical patent/JP2013544786A5/ja
Application granted granted Critical
Publication of JP5805773B2 publication Critical patent/JP5805773B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2013533941A 2010-10-12 2011-10-11 シクロスポリンアナログ Expired - Fee Related JP5805773B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US39245110P 2010-10-12 2010-10-12
US61/392,451 2010-10-12
PCT/US2011/055788 WO2012051193A1 (en) 2010-10-12 2011-10-11 Cyclosporin analogs

Publications (3)

Publication Number Publication Date
JP2013544786A JP2013544786A (ja) 2013-12-19
JP2013544786A5 true JP2013544786A5 (enExample) 2014-02-06
JP5805773B2 JP5805773B2 (ja) 2015-11-10

Family

ID=44883796

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2013533941A Expired - Fee Related JP5805773B2 (ja) 2010-10-12 2011-10-11 シクロスポリンアナログ

Country Status (12)

Country Link
US (2) US9175042B2 (enExample)
EP (1) EP2627663B1 (enExample)
JP (1) JP5805773B2 (enExample)
KR (1) KR20140026328A (enExample)
CN (1) CN103261212A (enExample)
AU (1) AU2011316689B2 (enExample)
BR (1) BR112013008749A2 (enExample)
CA (1) CA2814191A1 (enExample)
IL (1) IL225616A0 (enExample)
MX (1) MX2013004062A (enExample)
RU (1) RU2013120927A (enExample)
WO (1) WO2012051193A1 (enExample)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010138422A1 (en) * 2009-05-27 2010-12-02 Allergan, Inc. Cyclosporin derivatives for enhancing the growth of hair
BR112013014890B1 (pt) * 2010-12-15 2023-10-24 Contravir Pharmaceuticals, Inc Composto análogo de moléculas pertencentes à família ciclosporina, composição farmacêutica compreendendo o mesmo, uso terapêutico ou profilático do referido composto e processos para a preparação dos mesmos
JP2015519368A (ja) * 2012-06-01 2015-07-09 アラーガン インコーポレイテッドAllergan,Incorporated シクロスポリンa類似体
BR112015021388A2 (pt) 2013-03-08 2017-07-18 Allergan Inc conjugados esteroides de ciclosporina a
US9914755B2 (en) 2015-01-08 2018-03-13 Allergan, Inc. Cyclosporin derivatives wherein the MeBmt sidechain has been cyclized
WO2018106945A1 (en) 2016-12-07 2018-06-14 Progenity Inc. Gastrointestinal tract detection methods, devices and systems
JP2020513280A (ja) 2016-12-14 2020-05-14 プロジェニティ, インコーポレイテッド 消化管疾病の免疫抑制剤による治療
WO2019246312A1 (en) 2018-06-20 2019-12-26 Progenity, Inc. Treatment of a disease of the gastrointestinal tract with an immunomodulator
CN115028681B (zh) * 2022-08-11 2022-11-15 中国科学院微生物研究所 一种降解亲环素a的嵌合体化合物及其制备方法与应用

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4649047A (en) 1985-03-19 1987-03-10 University Of Georgia Research Foundation, Inc. Ophthalmic treatment by topical administration of cyclosporin
US5474979A (en) 1994-05-17 1995-12-12 Allergan, Inc. Nonirritating emulsions for sensitive tissue
FR2757522B1 (fr) * 1996-12-24 1999-01-29 Rhone Poulenc Rorer Sa Derives de cyclosporine, leur preparation et les compositions pharmaceutiques qui les contiennent
FR2757521B1 (fr) * 1996-12-24 1999-01-29 Rhone Poulenc Rorer Sa Nouveaux derives de cyclosporine, leur preparation et les compositions pharmaceutiques qui les contiennent
FR2762843B1 (fr) 1997-04-30 1999-12-10 Rhone Poulenc Rorer Sa Nouveaux derives de cyclosporine, leur preparation et les compositions pharmaceutiques qui les contiennent
FR2772768B1 (fr) * 1997-12-19 2000-01-14 Rhone Poulenc Rorer Sa Nouveau procede de preparation de derives de cyclosporine
CN1205220C (zh) 1998-06-12 2005-06-08 斯-凯穆公司 新颖的环孢菌素
US6254860B1 (en) * 1999-04-13 2001-07-03 Allergan Sales, Inc. Ocular treatment using cyclosporin-A derivatives
CN100478025C (zh) * 2005-03-25 2009-04-15 中国科学院上海药物研究所 一种环孢菌素a眼用微乳制剂及其制备方法
EP2023918B1 (en) * 2006-05-19 2011-03-23 Scynexis, Inc. Cyclosporins for the treatment and prevention of ocular disorders
RU2009144186A (ru) 2007-05-04 2011-06-10 Аллерган, Инк. (Us) Применение циклоспоринов при лечении пациентов с интраокулярными линзами
JP5661035B2 (ja) 2008-07-10 2015-01-28 アラーガン、インコーポレイテッドAllergan,Incorporated 眼および皮膚の疾患および症状の治療用のシクロスポリン誘導体
WO2012009715A2 (en) 2010-07-16 2012-01-19 S&T Global Inc. Novel cyclosporin derivatives for the treatment and prevention of a viral infection
US9573978B2 (en) * 2010-08-12 2017-02-21 S&T Global, Inc. Cyclosporin derivatives for the treatment and prevention of a viral infection
JP5805774B2 (ja) 2010-10-12 2015-11-10 アラーガン、インコーポレイテッドAllergan,Incorporated シクロスポリンアナログ
US9890198B2 (en) 2010-12-03 2018-02-13 S&T Global Inc. Cyclosporin derivatives and uses thereof
ES2625502T3 (es) 2010-12-03 2017-07-19 S&T Global Inc Nuevos derivados de ciclosporina para el tratamiento y prevención de una infección vírica

Similar Documents

Publication Publication Date Title
JP2013544786A5 (enExample)
CA3045733C (en) Compositions comprising tacrolimus for the treatment of intraocular inflammatory eye diseases
RU2013120927A (ru) Аналоги циклоспорина
JP2014525426A5 (enExample)
JP6779614B2 (ja) 水性点眼液
JP2013540776A5 (enExample)
RU2632107C2 (ru) Пероральная фармацевтическая композиция для профилактики или лечения синдрома "сухого глаза", содержащая ребамипид или его предшественник
JP2017523225A5 (enExample)
CN104520268A (zh) Ssao的取代的3-卤代烯丙基胺抑制剂及其用途
JP2014525427A5 (enExample)
RU2013119869A (ru) Аналоги циклоспорина
RU2011136250A (ru) Низкомолекулярное полисульфатированное производное гиалуроновой кислоты и содержащее его лекарственное средство
RU2012107109A (ru) Бициклическое соединение и его применение для медицинских целей
NO20075353L (no) Forbindelser, isomerer og farmasoytisk akseptable salter derav, som vanilloidreseptorantagonister, og farmasoytiske preparater inneholdende slike
JP2014502979A5 (enExample)
JP2019535723A5 (enExample)
JP2016537432A5 (enExample)
JP5856264B2 (ja) ポリエチレングリコール含有組成物
FI2765988T3 (fi) Silmäkoostumus, joka sisältää bromfenaakkia, jolla on parannettu biologinen hyötyosuus
JP2013537551A5 (enExample)
WO2013067409A1 (en) Antimicrobial carboline compounds
JP2017534658A5 (enExample)
JP2021534202A5 (enExample)
JP2019502719A5 (enExample)
JP6509244B2 (ja) 水晶体硬化抑制剤